KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Free Cash Flow (2018 - 2025)

ClearPoint Neuro's Free Cash Flow history spans 13 years, with the latest figure at -$3.3 million for Q3 2025.

  • For Q3 2025, Free Cash Flow fell 174.15% year-over-year to -$3.3 million; the TTM value through Sep 2025 reached -$13.6 million, down 52.65%, while the annual FY2024 figure was -$9.3 million, 35.76% up from the prior year.
  • Free Cash Flow for Q3 2025 was -$3.3 million at ClearPoint Neuro, down from -$2.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1.2 million in Q4 2023 and bottomed at -$6.2 million in Q1 2025.
  • The 5-year median for Free Cash Flow is -$3.4 million (2021), against an average of -$3.4 million.
  • The largest annual shift saw Free Cash Flow skyrocketed 61.66% in 2023 before it tumbled 174.15% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$3.6 million in 2021, then rose by 13.54% to -$3.1 million in 2022, then surged by 61.66% to -$1.2 million in 2023, then plummeted by 30.76% to -$1.6 million in 2024, then crashed by 113.37% to -$3.3 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Free Cash Flow are -$3.3 million (Q3 2025), -$2.5 million (Q2 2025), and -$6.2 million (Q1 2025).